Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT05226793
Eligibility Criteria:
Inclusion Criteria:
Effectiveness of intermediate-intensity vs standard prophylactic enoxaparin regimens on preventing DVT and/or PE in patients with COVID-19, measured using the following variables:
* Enoxaparin dose (appropriate for kidney function)
* Charlson comorbidity index (CCI) score
* Padua prediction score for risk of VTE
* IMPROVE \[International Medical Prevention Registry on VTE\] bleeding risk assessment score
* ICU status
* Number of thromboembolic events
* Length of stay
* Readmissions for DVT and/or PE
* In-hospital mortality with associated DVT or PE
Exclusion Criteria:
* Safety of intermediate-intensity vs standard prophylactic enoxaparin regimens in patients with COVID-19, measured using the following variables:
* Bleeding events
* Type of bleeding event
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05226793
Study Brief:
Protocol Section:
NCT05226793